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THE ROLE OF BLOOD PLATELETS IN IMMUNE SYSTEM 
Blood platelets are anucleate cells derived from the megakaryocyte series, and 
have long been considered only as cells responsible for coagulation and the fibrinolysis 
process. However, recently more data shows that they are also effector cells in the 
inflammatory response and important elements of the immunological response. Platelets 
store and release many biologically active substances, including growth factors, 
cytokines and chemokines, which actively affect i.a. elements of the immune system, and 
thus become regulators of immunity and mediators of inflammatory response. Their 
impact on the immune system cells is also associated with the induction of leucocytes and 
progenitor cells to the site of pathogen permeation or vascular injury inflow, as well as 
endothelial cells. Interacting with neutrophils, monocytes and lymphocytes, they not only 
activate them, but also form platelet-leukocyte aggregates that immobilise pathogens and 
prevent their spreading. Furthermore, platelets are capable of absorbing pathogens, 
affecting anti-infection immunity of the system. It is also assumed that the presence of 
receptors on their surface, such as Toll-like receptors (TLRs), affects their initiation and 
activity of the immunological response. 
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Characteristics of platelets. Platelets are anucleate cells derived from the 
megakaryocyte series, characterised by high morphological variation. Under resting 
conditions platelets are oval, without cell processes and surrounded with shapeless 
glycocalyx which prevents their sticking and adhesion e.g. to the endothelium [18, 19]. 
Their membrane is connected to an intercellular open canalicular system (OCS) which is 
necessary for their granule content exocytosis which takes part not only in coagulation 
and homeostasis, but also in inflammation and also activates the immune system 
[9,14,17,21,23]. The function of platelets during the immunological response is strictly 
connected with activation of their surface receptors, including the aforementioned TLR 
markers  and  the  Fc  receptor  which  recognises  immunoglobulins  G,  E  and  A  as  well  as  
selectin P and receptor CD40 [1,3,8,9,11,17,21].  
The most important receptors of platelets, in relation to immunological response, 
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are TLRs, which play a major role in the activation of immune system cells, determining 
the non-specific response, including elements of natural immunity and, indirectly, also 
the specific response, including acquired (adaptive) immunity components [1,17,21]. The 
receptors recognize exogenous and endogenous ligands and bind many various agonists 
and antagonists, such as antigens of many bacteria, viruses and auto-antigens of 
vertebrates and invertebrates [1,17,21]. The occurrence of TLRs on the surface of 
platelets is evidence of the fact that the cells evolve not only as hemostatic cells, but also 
as immune system cells, including cells recognizing antigens, such as bacterial 
lipopolysaccharide (LPS). It was evidenced that there are platelets with TLR 7 1,2,4,5,6 
and 9 receptors in humans [1,14,16,17,21]. Among them, the role of TLR 4 and 2 was 
very well recognised and described, as they are also present in mice platelets [1,14,21]. In 
vitro studies  revealed  that,  in  response  to  LPS,  TLR 4  affects  the  release  of  TNF? and  
induces an interaction between the activated platelets and PMN cells [21]. Furthermore, it 
was evidenced that TLR4 induces activation of platelets manifested by increasing their 
adhesion to PMN cell capacity as a result of LPS action. This leads to robust neutrophil 
activation and formation of neutrophil extracellular traps (NETs) which also prevents 
bacterial spreading and is very important in severe sepsis [6, 21]. Also, in vivo studies 
revealed that the expression of TLR 4 and TLR2 on platelets is changed in patients 
suffering from diseases related to inflammation of the organism, which evidences their 
role in immunity. This role is also confirmed by TLR9, present on the platelets, which 
recognizes bacterial DNA as well as other pathogen ligands, and its expression is 
increased after activation of platelets with thrombin. The presence of TLR 1, 5 and 6 on 
the platelets was only evidenced on the level of their expression, yet their role in the 
activation of platelets is still unknown. Another group of platelet receptors are Fc markers 
and related to them receptors, including Fc?RIIA, Glycoprotein VI (GPVI) and C-type 
lectin receptor (CLEC-2), activation of which occurs by phosphorylation of 
immunoreceptor tyrosine-based activation motifs (ITAM), present in the cytoplasmic part 
of these receptors, or by binding to subunit FcR? [5, 21]. 
The role of platelets in immunity.Platelets are important in the “formation” of 
immunity as the first cells occurring at the site of damage, pathogen permeation, as well 
as at the inflammation site [18, 21]. On the surface, of platelets, there is increased 
expression of receptors specific to antagonists and ligands binding platelets with activated 
endothelial cells or the stroma of vessels uncovered after infection or trauma, which 
results  in  their  activation  [18].  The  process  causes  a  shape  change  of  such  ceils  from  
smooth and oval to ameboid and also a change in their function, as they begin to secrete 
biologically active substances; this leads to the final and irreversible phase of activation, 
including aggregation [17, 18, 19]. Cytokines released by platelets, including growth 
factors and chemokines, regulate immunological response by mobilising and directing 
leucocytes to the site of the inflammation, and affect the activity of other immune system 
cells outside the circulatory system [6,14,18,21]. The role of platelets in the modulation 
of immunological responses has also been noted, pointing i.a. to the action of CD40T as a 
bridge between innate and adaptive immunity, as it was proven that this molecule induces 
maturation of dendritic cells (DC) a base for development of adaptive immunity in 
response to infections [8,16,17,21]. It was also observed that platelets activated in 
response to viral infections can affect CD40T-depenclent differentiation of B ceils and 
switching of immunoglobulin classes, as well as the response of active CD8+ T cells by 
enhancing their cytotoxic properties against viral antigens [8,16,17,21]. It was 
hypothesized that platelets affect signal transmission to the interior of various immune 
system cells as it was evidenced that CD40L causes an increase in IgG secretion even 
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when the number of helper T cells with receptor CD4+ is reduced. Hence the 
presumption [7,8] in physiological conditions where the number of B and T cells and 
their antigen-specific response is weakened, platelets take over the functions of Y cells 
and cause signal transmission to B cells, in the direction of stimulating specific humoral 
response. During the inflammation, platelets also affect leucocytes, which leads to the 
formation of aggregates with neutrophils, monocytes and lymphocytes [16, 21]. This is 
possible owing to P-seleetin present on the membrane of the activated platelets, which 
binds to P-selectin glycoprotein ligand-1 (PSGL-1), present on the surface of leucocytes. 
Owing to this, the leucocyte CDl1b/CD18-receptoi (Mac-1) is activated and, together 
with platelet glycoprotein Ilb/IIIa, binds to fibrinogen, causing strengthening of the bond 
and formation of platelet-leucocyte aggregates [16,18,21]. P-selectin presented on the 
surface of activated platelets not only allows their binding to leucocytes, but can also 
affect activation of leucocytes themselves. It was evidenced that P-selectin, as mentioned 
earlier, apart from the production of superoxide anion radical in neutrophils and 
monocytes, together with PAF and RANTES, can stimulate monocytes to synthesis of IL-
8,  MCP-1,  j  MIPl-? and  TNF  ? [21,23].  Another  mechanism  by  which  platelets  can  
impact the activity of immune system cells is their interaction with the triggering receptor 
expressed on myeloid cells 1 (TREM-1) present mainly on neutrophils and monocytes 
proved that ligand for this receptor is largely expressed in human platelets [10,17]. They 
also evidenced that interaction between platelets and neutrophils in the presence of LPS 
increases TREM-1-dependent neutrophil activation, which results in increased production 
of reactive oxygen species and release of IL-8 [10]. It was also evidenced that neutrophil-
platelet complexes carry out phagocytosis, cytotoxicity or cytolysis more actively than 
single circulating neutrophils. It was also observed that platelets affect PMN cells causing 
formation of NETs, mainly in bacterial infections e.g. in severe sepsis [17,21]. In vitro 
studies of this process indicate the major role of platelet TLR4, which is responsible for 
binding bacterial LPS [6]. It was also evidenced that interaction of platelets and 
monocytes induces translocation of nuclear factor kappa-light-chain-enhancer of 
activated B cells (NF-kB), and expression of NF-kB-dependent genes and proteins-in 
monocytes, involved in the regulation of the inflammation, as a result of action of 
platelet-derived RANTES, IL-ip and PAF, which increase the secretion of e.g. TNF?, IL-
8 and MCP-1 in monocytes [18,21]. In vitro studies indicate that platelets also contribute 
to acceleration of chemokine synthesis in monocytes, and that they can provide the 
“signal" which triggers monocyte differentiation into DC cells rather than into settled 
macrophages [21]. 
The least data refer to the interaction between platelets and lymphocytes; it is only 
known that activated platelets secrete substances acting as chemoattractants and have an 
activating effect on helper T cells (Th), cytotoxic T cells (Tc), and NK cells, as well as B 
cells [13]. As mentioned earlier, T cells can contribute to platelet secretion of RANTES 
chemokine, as a result of a mechanism dependent on CD40L-CD40, which increases the 
inflow of lymphocytes to the inflammation site. Also, platelets facilitate lymphocyte 
aggregation in lymph nodes, which contributes to the formation of immunological 
memory [21]. Moreover, platelets activate Tc cells in response to viral infections, e.g. 
during hepatitis B virus infection, as they affect the accumulation of such lymphocytes in 
the liver [17]. It was evidenced that the role of platelets in anti-infection immunity of the, 
system is related to the fact that they are capable of destroying pathogens both indirectly 
– by involving other cells of the immune system, as well as directly, by secretion of 
substances destroying and damaging bacteria, such as PMP or reactive forms of oxygen 
[14,16,21]. Furthermore, their effect on pathogens is not only limited to the release of 
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active substances from granules, but they are also capable of absorbing small extraneous 
molecules via an open canalicular system, without activation or changing shape [19]. 
They detect bacteria in the circulatory system and surround them by adhesion, and hence 
it is assumed that their activity can be helpful in “clearing” microorganisms from the 
blood, which prevents their spreading across the system, even despite the fact that they 
are not professional phagocytes [18,19]. 
Conclusion. Previous studies on platelets, which once were regarded only as 
megakaryocyte cytoplasm fragments, indicate that they constitute an important element of 
the immune system, including, natural immunity, and also of acquired immunity by their 
interaction  with  B  cells.  This  is  due  to  their  unique  properties,  such  as  the  capacity  of  
expressing receptors and secretion of pro- and anti-inflammatory substances, as well as 
their capacity of interaction with granulocytes, monocytes and lymphocytes. The data 
indicate the important role in platelet function as ar essential element in maintaining the 
antigen integrity of the entire organism. 
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